Europe in-vitro colorectal cancer screening tests market size to cross USD 515 billion by 2026

The latest report ‘Europe in-vitro colorectal cancer screening tests market’ report acquaints businesses and other stakeholders with the key growth drivers, restraints, as well as the present and upcoming opportunities to aid in decision-making and sculpt future investments. It presents a comprehensive outlook for 2020-2026, explicating the business chain structure and explaining the industry environment, size, and shares in terms of test type and geographical fragmentation. Further, the study hosts competitor analysis to help industry partakers understand the winning strategies of key players that includes but are not limited to new product launches, agreements, partnerships, joint ventures, and acquisitions.

According to industry experts, Europe in-vitro colorectal cancer screening tests market is projected to surpass USD 515 billion by 2026, largely due to technological advancements in cancer screening tests and escalating cases of colon and rectal cancer. Moreover, introduction of transnational and national population-wide screening programs by the EU, coupled with favorable reimbursement policies. On the contrary, stringent government regulations for screening tests may negatively impact the industry dynamics in the forthcoming years.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2940280/

Test type overview:

Europe in-vitro colorectal cancer screening tests industry is categorized into fecal occult blood test, CRC DNA screening test, and biomarker test. Of these, fecal occult blood test (FOBT) segment was valued USD 312 million in 2019 and is expected to grow substantially over the forecast timeframe, creditable to easy use and cost efficiency of this test. Moreover, emergence of Immuno-FOBT for early detection of colorectal cancer has enhanced specificity and screening of stool-based screening tests, which further contributes to the segmental growth.

Geographical scope:

Key contributors to Europe in-vitro colorectal cancer screening tests market remuneration are United Kingdom, Germany, France, Spain, Italy, The Netherlands, Russia, Denmark, Sweden, Poland, and Norway. Among these Germany market led the industry growth in the recent past and is likely to showcase strong growth trends over the projected timeline. This can be ascribed to ahead of the curve utilization of screening tests for prevention of bowel cancer, along with rising awareness regarding cancer. Moreover, favorable reimbursement scenario in the nation is benefiting the business landscape. In fact, a full insurance reimbursement is available for screening colonoscopy for people aged 55 years and above residing in Germany.

Meanwhile, Italy in-vitro colorectal cancer screening tests industry size is to slated to expand at 6.1% CAGR throughout 2026. Factors such as advancements in diagnostics and treatments, aging population, and increasing cancer-associated risk factors are contributing to the industry expansion in the country.

To access a sample pages of this report titled “Europe In-vitro Colorectal Cancer Screening Tests Market Size By Test Type Industry Analysis Report, Regional Outlook Potential, Competitive Market Share & Forecast, 2020 - 2026” in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/europe-in-vitro-colorectal-cancer-screening-tests-market

Competitive terrain:

Top competitors in Europe in-vitro colorectal cancer screening tests market sphere are Sysmex Corp., Siemens Healthineers AG, Roche Molecular Systems, Inc., R-Biopharm AG, Randox Laboratories Ltd., Quest Diagnostics, and Qiagen N.V. among others. These players are undertaking strategies such as new product development, collaborations, and agreement to improve their presence and capture a bigger share of the market. For instance, Novigenix SA, in July 2017, signed a distribution agreement with Risch Medical Laboratory, enabling Novigenix to access the German market for the Colox product used for colorectal cancer test.

Europe In-vitro Colorectal Cancer Screening Tests Market Test Types (Revenue, USD Million, 2015-2026)

Fecal Occult Blood Test

  • Immuno-FOB Agglutination Test
  • Guaiac FOB Stool Test
  • Immuno-FOB ELISA Test
  • Lateral Flow Immuno-FOB Test

Biomarker Test

  • Tumor M2-PK Stool Test
  • Transferring Assays
  • CRC DNA Screening Test

CRC DNA Screening Test

  • Panel DNA Test
  • Methylated Gene Test

Europe In-vitro Colorectal Cancer Screening Tests Market Geographical Fragmentation (Revenue, USD Million, 2015-2026)

  • United Kingdom
  • Germany
  • France
  • Spain
  • Italy
  • The Netherlands
  • Russia
  • Denmark
  • Sweden
  • Poland
  • Norway

Europe In-vitro Colorectal Cancer Screening Tests Market Company Profiles (Revenue, USD Million, 2015-2026)

  • Sysmex Corp.
  • Siemens Healthineers AG
  • Roche Molecular Systems, Inc.
  • R-Biopharm AG
  • Randox Laboratories Ltd.
  • Quest Diagnostics
  • Qiagen N.V.
  • Novigenix SA
  • Kyowa Kirin Co., Ltd.
  • Epigenomics AG
  • Merck Millipore
  • Beckman Coulter, Inc.
  • Abbott Laboratories

Related Report:

In-vitro Diagnostics Market Size, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

In-vitro Diagnostics Market will exceed USD 97.2 billion by 2025, as per a new research report. Increasing number of pathology labs equipped with advanced diagnostics machine will prove beneficial for in-vitro diagnostics market growth in near future. Now a days, pathology labs are incorporating latest technology instruments to provide superior quality services to patients. Moreover, advanced technology enables in detection of several diseases before their onset. This in turn enhances overall clinical outcome that will prevent further complications. As a result, growing number of laboratories incorporating technologically advanced machines will augment in-vitro diagnostics market growth over the forecast period. About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

 
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
News: http://business-newsupdate.com/

Back to news